Definitive Healthcare (NASDAQ:DH) Stock Crosses Above 200-Day Moving Average - Should You Sell?

Key Points

• Definitive Healthcare shares rose above their 200-day moving average, reaching $1.15 before last trading at $1.14, compared with a 200-day average of $1.11.
• Analyst sentiment remains cautious: the stock has an average “Reduce” rating and a consensus price target of $1.47, despite one recent upgrade to “Buy.”
• The company narrowly exceeded quarterly EPS expectations but missed revenue estimates and continues to report a deeply negative net margin; institutional investors own 98.67% of the stock.

Definitive Healthcare Corp. (NASDAQ:DH - Get Free Report) shares crossed above its two hundred day moving average during trading on Wednesday. The stock has a two hundred day moving average of $1.11 and traded as high as $1.15. Definitive Healthcare shares last traded at $1.14, with a volume of 472,430 shares changing hands.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. Wall Street Zen upgraded shares of Definitive Healthcare from a "hold" rating to a "buy" rating in a research note on Sunday, September 13th. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating and issued a $1.00 price target on shares of Definitive Healthcare in a report on Wednesday, August 12th. Morgan Stanley dropped their price objective on Definitive Healthcare from $2.50 to $1.50 and set an "equal weight" rating on the stock in a research note on Tuesday, August 11th. Weiss Ratings restated a "sell (e+)" rating on shares of Definitive Healthcare in a report on Monday, August 31st. Finally, BTIG Research reaffirmed a "neutral" rating on shares of Definitive Healthcare in a research report on Friday, September 4th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Reduce" and a consensus price target of $1.47.

Definitive Healthcare Price Performance

The company has a current ratio of 1.86, a quick ratio of 1.86 and a debt-to-equity ratio of 0.81. The firm's 50-day moving average price is $0.96 and its two-hundred day moving average price is $1.11. The stock has a market cap of $121.69 million, a PE ratio of -0.71, a PEG ratio of 13.33 and a beta of 1.40.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last issued its quarterly earnings data on Monday, August 10th. The company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.01. The company had revenue of $55.20 million for the quarter, compared to analyst estimates of $55.47 million. Definitive Healthcare had a negative net margin of 72.28% and a positive return on equity of 3.55%. Definitive Healthcare has set its FY 2026 guidance at 0.180-0.200 EPS and its Q3 2026 guidance at 0.040-0.050 EPS. On average, equities analysts expect that Definitive Healthcare Corp. will post 0.06 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in DH. Irenic Capital Management LP acquired a new stake in Definitive Healthcare in the first quarter valued at approximately $71,000. Williams & Novak LLC grew its holdings in Definitive Healthcare by 155.8% in the second quarter. Williams & Novak LLC now owns 78,610 shares of the company's stock worth $65,000 after purchasing an additional 47,880 shares during the last quarter. Williams & Novak Wealth Management LLC increased its position in shares of Definitive Healthcare by 15.3% during the third quarter. Williams & Novak Wealth Management LLC now owns 90,610 shares of the company's stock worth $82,000 after purchasing an additional 12,000 shares in the last quarter. Squarepoint Ops LLC increased its position in shares of Definitive Healthcare by 46.5% during the second quarter. Squarepoint Ops LLC now owns 351,575 shares of the company's stock worth $292,000 after purchasing an additional 111,634 shares in the last quarter. Finally, Corient Private Wealth LP acquired a new stake in shares of Definitive Healthcare in the 2nd quarter worth $378,000. 98.67% of the stock is owned by institutional investors.

About Definitive Healthcare

Definitive Healthcare Corp. NASDAQ: DH provides data, analytics and commercial intelligence solutions for the healthcare industry. Its platform is designed to help organizations understand healthcare markets, identify business opportunities and make data-driven decisions.

The company serves pharmaceutical and biotechnology companies, medical device manufacturers, healthcare providers, hospitals and health systems, and other healthcare services organizations. Its offerings include information on healthcare providers and organizations, market intelligence, sales and marketing analytics, clinical trial insights, and tools that support commercial planning, market access and customer engagement.

Definitive Healthcare was founded in 2011 and became a publicly traded company in 2021.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.